NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Strados Labs

Strados Labs

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://stradoslabs.com/

Last Round

Grant

Mar 10, 2022

Total Funding Raised

$7.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Strados Labs is a medical technology company that provides a wearable biosensor and respiratory endpoint intelligence platform for clinical trials and remote patient monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials, Healthcare Analytics, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

remote patient monitoringRPMrespiratory healthwearable sensordigital healthclinical trialsrespiratory monitoringhealth IoTmedical devicehealthcare analyticsmachine learningclinical decision supportdigital biomarkerSaaSconnected health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Strados Labs Comparables

Compare Strados Labs with similar companies based on industry and business-model similarity.

Strados Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aevice Health
88%
Health Care Originals
85%
Respiree
85%

Strados Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 10, 2022
Series AJan 5, 2022
GrantAug 13, 2020
DebtMay 27, 2020
SeedMay 9, 2019
Pre Seed
Nov 16, 2017

Key People

Founding team and executive leadership

Richard Powers

Chief Product Officer & Founder

Founding Team

Nick Delmonico

Founder And CEO

Founding Team

Strados Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Digital respiratory measurement platform receives FDA clearance.

  • Apr 23, 2025

    Will present developments in Cough Monitoring at ATS 2025.

Strados Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Strados Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Strados Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range48
Year Founded2016
Last FundingMar 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.